182 related articles for article (PubMed ID: 29071359)
1. Bone marrow failure and extramedullary hematopoiesis in McCune-Albright syndrome.
Robinson C; Boyce AM; Estrada A; Kleiner DE; Mathew R; Stanton R; Frangoul H; Collins MT
Osteoporos Int; 2018 Jan; 29(1):237-241. PubMed ID: 29071359
[TBL] [Abstract][Full Text] [Related]
2. Severe aplastic anemia-paroxysmal nocturnal hemoglobinuria syndrome in a patient with non-A-E hepatitis virus infection.
Shaaban H; Gauchan D; Kahlon A; Maroules M
Ann Hepatol; 2014; 13(4):466-7. PubMed ID: 24927620
[No Abstract] [Full Text] [Related]
3. McCune-Albright syndrome-associated bone marrow failure and extramedullary haematopoeisis secondary to fibrous dysplasia.
Mahdi AJ; Connor P; Thakur I
Br J Haematol; 2017 Jul; 178(2):179. PubMed ID: 28612379
[No Abstract] [Full Text] [Related]
4. An altered gut microbiota may trigger autoimmune-mediated acquired bone marrow failure syndromes.
Espinoza JL; Elbadry MI; Nakao S
Clin Immunol; 2016 Oct; 171():62-64. PubMed ID: 27506961
[No Abstract] [Full Text] [Related]
5. Disease modeling of bone marrow failure syndromes using iPSC-derived hematopoietic stem progenitor cells.
Elbadry MI; Espinoza JL; Nakao S
Exp Hematol; 2019 Mar; 71():32-42. PubMed ID: 30664904
[TBL] [Abstract][Full Text] [Related]
6. p53 Mediates Failure of Human Definitive Hematopoiesis in Dyskeratosis Congenita.
Fok WC; Niero ELO; Dege C; Brenner KA; Sturgeon CM; Batista LFZ
Stem Cell Reports; 2017 Aug; 9(2):409-418. PubMed ID: 28757166
[TBL] [Abstract][Full Text] [Related]
7. [Bone marrow failure syndrome (idiopathic hematopoietic disorders): progress in diagnosis and treatment. Topics: I. Pathogenesis and pathophysiology of bone-marrow failure; 1. Aplastic anemia].
Nakao S
Nihon Naika Gakkai Zasshi; 2012 Jul; 101(7):1882-90. PubMed ID: 22896990
[No Abstract] [Full Text] [Related]
8. Telomerase enzyme activity in Egyptian children with bone marrow failure and response to immunosuppressive therapy.
El Beshlawy A; Said F; El Ansary M; Hamdy M; Abdel-Azim K; Abdel-Razek AA; Abulata N; Abdel-Salam A
Blood Cells Mol Dis; 2017 Mar; 63():58-61. PubMed ID: 28160733
[No Abstract] [Full Text] [Related]
9. Introduction to Acquired and Inherited Bone Marrow Failure.
Sieff CA
Hematol Oncol Clin North Am; 2018 Aug; 32(4):569-580. PubMed ID: 30047411
[TBL] [Abstract][Full Text] [Related]
10. Craniofacial Fibrous Dysplasia: Clinical and Therapeutic Implications.
Szymczuk V; Taylor J; Boyce AM
Curr Osteoporos Rep; 2023 Apr; 21(2):147-153. PubMed ID: 36849642
[TBL] [Abstract][Full Text] [Related]
11. Guest Editorial: Inherited bone marrow failure and myelodysplasia in children: how much do we know about pediatric diseases?
Manabe A
Int J Hematol; 2016 Apr; 103(4):359. PubMed ID: 26899856
[No Abstract] [Full Text] [Related]
12. Rapamycin is highly effective in murine models of immune-mediated bone marrow failure.
Feng X; Lin Z; Sun W; Hollinger MK; Desierto MJ; Keyvanfar K; Malide D; Muranski P; Chen J; Young NS
Haematologica; 2017 Oct; 102(10):1691-1703. PubMed ID: 28729300
[TBL] [Abstract][Full Text] [Related]
13. Dental perspectives in fibrous dysplasia and McCune-Albright syndrome.
Akintoye SO; Boyce AM; Collins MT
Oral Surg Oral Med Oral Pathol Oral Radiol; 2013 Sep; 116(3):e149-55. PubMed ID: 23953425
[TBL] [Abstract][Full Text] [Related]
14. Lesion Expansion in Gnathic Fibrous Dysplasia: Natural History, Indicators of Progression, and Response to Bisphosphonates.
Pan KS; Taylor J; Szymczuk V; Boyce AM
J Bone Miner Res; 2023 Oct; 38(10):1465-1471. PubMed ID: 37477421
[TBL] [Abstract][Full Text] [Related]
15. Aplastic Anemia and MDS International Foundation (AAMDSIF): Bone marrow failure disease scientific symposium 2016.
Zeidan AM; Battiwalla M; Berlyne D; Winkler T
Leuk Res; 2017 Feb; 53():8-12. PubMed ID: 27923195
[TBL] [Abstract][Full Text] [Related]
16. Fracture incidence in polyostotic fibrous dysplasia and the McCune-Albright syndrome.
Leet AI; Chebli C; Kushner H; Chen CC; Kelly MH; Brillante BA; Robey PG; Bianco P; Wientroub S; Collins MT
J Bone Miner Res; 2004 Apr; 19(4):571-7. PubMed ID: 15005844
[TBL] [Abstract][Full Text] [Related]
17. Hematologic Manifestations of Deficiency of Adenosine Deaminase 2 (DADA2) and Response to Tumor Necrosis Factor Inhibition in DADA2-Associated Bone Marrow Failure.
Michniacki TF; Hannibal M; Ross CW; Frame DG; DuVall AS; Khoriaty R; Vander Lugt MT; Walkovich KJ
J Clin Immunol; 2018 Feb; 38(2):166-173. PubMed ID: 29411230
[No Abstract] [Full Text] [Related]
18. Long Bone Fractures in Fibrous Dysplasia/McCune-Albright Syndrome: Prevalence, Natural History, and Risk Factors.
Geels RES; Meier ME; Saikali A; Tsonaka R; Appelman-Dijkstra NM; Boyce AM
J Bone Miner Res; 2022 Feb; 37(2):236-243. PubMed ID: 34668234
[TBL] [Abstract][Full Text] [Related]
19. Extent of Extraskeletal Manifestations of Fibrous Dysplasia/McCune-Albright Syndrome in Patients with Mazabraud's Syndrome.
Hagelstein-Rotman M; Appelman-Dijkstra NM; Boyce AM; Chapurlat R; Dur NBJ; Gensburger D; Majoor BCJ; van de Sande MAJ; Dijkstra PDS
Calcif Tissue Int; 2022 Mar; 110(3):334-340. PubMed ID: 34854944
[TBL] [Abstract][Full Text] [Related]
20. Analyses of variable panoramic radiographic characteristics of maxillo-mandibular fibrous dysplasia in McCune-Albright syndrome.
Akintoye SO; Otis LL; Atkinson JC; Brahim J; Kushner H; Robey PG; Collins MT
Oral Dis; 2004 Jan; 10(1):36-43. PubMed ID: 14996293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
